77. Januzzi JL Jr., Rehman SU, Mohammed AA, et al. Use of amino- terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction. J Am Coll Cardiol 2011;58:1881 9. 78. Porapakkham P, Porapakkham P, Zimmet H, et al. B-type natriuretic peptide-guided heart failure therapy: a meta-analysis. Arch Intern Med 2010;170:507 14. 79. Felker GM, Hasselblad V, Hernandez AF, et al. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials. Am Heart J 2009;158:422 30. 80. Jourdain P, Jondeau G, Funck F, et al. Plasma brain natriuretic peptide- guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J Am Coll Cardiol 2007;49:1733 9. 81. P sterer M, Buser P, Rickli H, et al. BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensi ed vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial. JAMA 2009;301:383 92. 82. Berger R, Moertl D, Peter S, et al. N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisci- plinary care in chronic heart failure: a 3-arm, prospective, randomized pilot study. J Am Coll Cardiol 2010;55:645 53. 83. Troughton RW, Frampton CM, Yandle TG, et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N- BNP) concentrations. Lancet 2000;355:1126 30. 84. Lainchbury JG, Troughton RW, Strangman KM, et al. N-terminal pro-B- type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial. J Am Coll Cardiol 2009;55:53 60. 85. Horwich TB, Patel J, MacLellan WR, et al. Cardiac troponin I is asso- ciated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 2003;108:833 8. 86. Sato Y, Yamada T, Taniguchi R, et al. 